Материалы доступны только для специалистов сферы здравоохранения.
Чтобы посмотреть материал полностью
Авторизуйтесь
или зарегистрируйтесь.
Ведение беременностей, наступивших после экстракорпорального оплодотворения у женщин с привычным невынашиванием, обусловленным иммунологическими нарушениями
Ведение беременностей, наступивших после экстракорпорального оплодотворения у женщин с привычным невынашиванием, обусловленным иммунологическими нарушениями
Материалы доступны только для специалистов сферы здравоохранения.
Чтобы посмотреть материал полностью
Авторизуйтесь
или зарегистрируйтесь.
Полный текст
Список литературы
1. Ghazeeri GS, Kutteh WH. Immunological testing and treatment in reproduction: frequency assessment of practice patterns at assisted reproduction clinics in the USA and Australia. Hum Reprod 2001; 16 (10): 2130–5.
2. Laird SM, Tuckerman EM, Li TC. Cytokine expression in the endometrium of women with implantation failure and recurrent miscarriage. Reprod Biomed Online 2006; 13 (1): 13–23.
3. Tomassetti C, Meuleman C, Pexsters A et al. Endometriosis, recurrent miscarriage and implantation failure: is there an immunological link? Reprod Biomed Online. 2006; 13 (1): 58–64.
4. Christiansen O.B. Evidence-based investigations and treatments of recurrent pregnancy loss. Curr Opin Obstet Gynecol 2006; 18 (3): 304–12.
5. Szekeres-Bartho J, Faust Z, Varga P et al. The immunological pregnancy protective effect of progesterone is manifested via controlling cytokine production. Am J Reprod Immunol 1996; 35 (4): 348–51.
6. Halbmayer WM, Feichtinger W, Kindermann C et al. Recurrent miscarriage or failed in-vitro fertilization: antibodies against annexin V, cardiolipin, beta-2-glycoprotein-1 and APC-resistance. Hamostaseologie 2005; 25 (4): 391–3.
7. Heilmann L. Antithrombotic therapy in high risk pregnancy. Hematol Oncology Clin North Am 2000; 13 (5): 1133–50.
8. Matsubayashi H, Arai T, Izumi S. Anti-annexin V antibodies in patients with early pregnancy loss or implantation failures. Fertil Steril 2001; 76 (4): 694–9.
9. Stern C, Chamley L. Antiphospholipid antibodies and coagulation defects in women with implantation failure after IVF and recurrent miscarriage. Reprod Biomed Online 2006; 13 (1): 29–37.
10. Stern C, Chamley L, Hale L et al. Antibodies to beta2 glycoprotein I are associated with in vitro fertilization implantation failure as well as recurrent miscarriage: results of a prevalence study. Fertil Steril 1998; 70 (5): 938–44.
11. Nardo LG, Sallam HN. Progesterone supplementation to prevent recurrent miscarriage and to reduce implantation failure in assisted reproduction cycles. Reprod Biomed Online 2006; 13 (1): 47–57.
2. Laird SM, Tuckerman EM, Li TC. Cytokine expression in the endometrium of women with implantation failure and recurrent miscarriage. Reprod Biomed Online 2006; 13 (1): 13–23.
3. Tomassetti C, Meuleman C, Pexsters A et al. Endometriosis, recurrent miscarriage and implantation failure: is there an immunological link? Reprod Biomed Online. 2006; 13 (1): 58–64.
4. Christiansen O.B. Evidence-based investigations and treatments of recurrent pregnancy loss. Curr Opin Obstet Gynecol 2006; 18 (3): 304–12.
5. Szekeres-Bartho J, Faust Z, Varga P et al. The immunological pregnancy protective effect of progesterone is manifested via controlling cytokine production. Am J Reprod Immunol 1996; 35 (4): 348–51.
6. Halbmayer WM, Feichtinger W, Kindermann C et al. Recurrent miscarriage or failed in-vitro fertilization: antibodies against annexin V, cardiolipin, beta-2-glycoprotein-1 and APC-resistance. Hamostaseologie 2005; 25 (4): 391–3.
7. Heilmann L. Antithrombotic therapy in high risk pregnancy. Hematol Oncology Clin North Am 2000; 13 (5): 1133–50.
8. Matsubayashi H, Arai T, Izumi S. Anti-annexin V antibodies in patients with early pregnancy loss or implantation failures. Fertil Steril 2001; 76 (4): 694–9.
9. Stern C, Chamley L. Antiphospholipid antibodies and coagulation defects in women with implantation failure after IVF and recurrent miscarriage. Reprod Biomed Online 2006; 13 (1): 29–37.
10. Stern C, Chamley L, Hale L et al. Antibodies to beta2 glycoprotein I are associated with in vitro fertilization implantation failure as well as recurrent miscarriage: results of a prevalence study. Fertil Steril 1998; 70 (5): 938–44.
11. Nardo LG, Sallam HN. Progesterone supplementation to prevent recurrent miscarriage and to reduce implantation failure in assisted reproduction cycles. Reprod Biomed Online 2006; 13 (1): 47–57.
Авторы
А.А.Агаджанова, Н.К.Тетруашвили, В.М.Сидельникова, Л.Н.Кузьмичев, Г.Т.Сухих
ГУ Научный центр акушерства, гинекологии и перинатологии (дир. – акад. РАМН В.И.Кулаков), Москва
ГУ Научный центр акушерства, гинекологии и перинатологии (дир. – акад. РАМН В.И.Кулаков), Москва
Цель портала OmniDoctor – предоставление профессиональной информации врачам, провизорам и фармацевтам.